A detailed history of Cardinal Capital Management transactions in Pfizer Inc stock. As of the latest transaction made, Cardinal Capital Management holds 92,506 shares of PFE stock, worth $2.54 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares
92,506
Previous 90,416 2.31%
Holding current value
$2.54 Million
Previous $2.53 Million 5.85%
% of portfolio
0.42%
Previous 0.43%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$27.7 - $31.39 $57,893 - $65,605
2,090 Added 2.31%
92,506 $2.68 Million
Q2 2024

Jul 12, 2024

BUY
$25.26 - $29.6 $40,542 - $47,508
1,605 Added 1.81%
90,416 $2.53 Million
Q1 2024

Jul 12, 2024

BUY
$25.89 - $29.73 $281,243 - $322,956
10,863 Added 13.94%
88,811 $2.46 Million
Q1 2024

Apr 15, 2024

BUY
$25.89 - $29.73 $281,243 - $322,956
10,863 Added 13.94%
88,811 $2.46 Million
Q4 2023

Jul 12, 2024

BUY
$26.13 - $33.94 $1.24 Million - $1.62 Million
47,619 Added 157.01%
77,948 $2.24 Million
Q4 2023

Jan 26, 2024

BUY
$26.13 - $33.94 $1.24 Million - $1.62 Million
47,619 Added 157.01%
77,948 $2.24 Million
Q3 2023

Jul 12, 2024

BUY
$32.09 - $37.51 $38,026 - $44,449
1,185 Added 4.07%
30,329 $1.01 Million
Q3 2023

Oct 16, 2023

BUY
$32.09 - $37.51 $38,026 - $44,449
1,185 Added 4.07%
30,329 $1.01 Million
Q2 2023

Jul 12, 2024

SELL
$36.12 - $41.79 $2.16 Million - $2.49 Million
-59,667 Reduced 67.18%
29,144 $1.07 Million
Q2 2023

Jul 12, 2023

SELL
$36.12 - $41.79 $2.12 Million - $2.46 Million
-58,801 Reduced 66.86%
29,144 $1.07 Million
Q1 2023

Apr 18, 2023

BUY
$39.39 - $51.28 $66,135 - $86,099
1,679 Added 1.95%
87,945 $3.59 Million
Q4 2022

Jan 20, 2023

BUY
$41.75 - $54.5 $127,963 - $167,042
3,065 Added 3.68%
86,266 $0
Q3 2022

Oct 21, 2022

BUY
$43.76 - $53.42 $244,224 - $298,137
5,581 Added 7.19%
83,201 $3.64 Million
Q2 2022

Aug 04, 2022

BUY
$46.53 - $55.17 $3.61 Million - $4.28 Million
77,620 New
77,620 $4.07 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Cardinal Capital Management Portfolio

Follow Cardinal Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cardinal Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Cardinal Capital Management with notifications on news.